Hudson Bay Capital Management LP Rocket Pharmaceuticals, Inc. Transaction History
Hudson Bay Capital Management LP
- $24.1 Billion
- Q4 2024
A detailed history of Hudson Bay Capital Management LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 113,500 shares of RCKT stock, worth $861,465. This represents 0.01% of its overall portfolio holdings.
Number of Shares
113,500
Previous 65,000
74.62%
Holding current value
$861,465
Previous $1.2 Million
18.83%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding RCKT
# of Institutions
242Shares Held
94.3MCall Options Held
262KPut Options Held
159K-
Rtw Investments, LP New York, NY17.7MShares$134 Million3.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.58MShares$49.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$47 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$39.5 Million1.26% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.71MShares$35.8 Million0.27% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $574M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...